Clinical and therapeutic features of myasthenia gravis in adults based on age at onset
- 17 March 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 94 (11), e1171-e1180
- https://doi.org/10.1212/wnl.0000000000008903
Abstract
Objective To describe the characteristics of patients with very-late-onset myasthenia gravis (MG). Methods This observational cross-sectional multicenter study was based on information in the neurologist-driven Spanish Registry of Neuromuscular Diseases (NMD-ES). All patients were >18 years of age at onset of MG and onset occurred between 2000 and 2016 in all cases. Patients were classified into 3 age subgroups: early-onset MG (age at onset Results A total of 939 patients from 15 hospitals were included: 288 (30.7%) had early-onset MG, 227 (24.2%) late-onset MG, and 424 (45.2%) very-late-onset MG. The mean follow-up was 9.1 years (SD 4.3). Patients with late onset and very late onset were more frequently men (p < 0.0001). Compared to the early-onset and late-onset groups, in the very-late-onset group, the presence of anti–acetylcholine receptor (anti-AChR) antibodies (p < 0.0001) was higher and fewer patients had thymoma (p < 0.0001). Late-onset MG and very-late-onset MG groups more frequently had ocular MG, both at onset (p = 0.001). Although the very-late-onset group presented more life-threatening events (Myasthenia Gravis Foundation of America IVB and V) at onset (p = 0.002), they required fewer drugs (p < 0.0001) and were less frequently drug-refractory (p < 0.0001). Conclusions Patients with MG are primarily ≥65 years of age with anti-AChR antibodies and no thymoma. Although patients with very-late-onset MG may present life-threatening events at onset, they achieve a good outcome with fewer immunosuppressants when diagnosed and treated properly.This publication has 39 references indexed in Scilit:
- Myasthenia gravis and the neuromuscular junctionCurrent Opinion in Neurology, 2013
- Age-related autoimmunityBMC Medicine, 2013
- A systematic review of population based epidemiological studies in Myasthenia GravisBMC Neurology, 2010
- Increasing incidence of elderly onset patients with myasthenia gravis in a local area of JapanJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- 157th ENMC International Workshop: Patient registries for rare, inherited muscular disorders 25–27 January 2008 Naarden, The NetherlandsNeuromuscular Disorders, 2008
- Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravisBrain, 2003
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986
- Autoimmune Response to Acetylcholine ReceptorScience, 1973
- St. Thomas's Hospital.The Lancet, 1823